Pharma Marketing Blog represents the opinions of
John Mack
Publisher of
Pharma Marketing News.
We accept advertising relevant to the interests of our members.
For more information, see:
Media Kit
Operated by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
|
My Humble Opinion
|
Other People's Opinion
|
|
A "Must Read" Blog for Insiders. -- Wall Street Journal
|
A bi-weekly podcast. Listen and call-in live online or download to your iPod!
|
Rozerem, Lunesta, Ambien, and Other Sleep Aid Drug Blog Topics
| Return to All Pharma Marketing Blog Topics |
If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe.
Listed in reverse chronological order:
- Sepracor Not So Keen to Spend Big on DTC for Its Next Product!
- Lunesta Moth Being Mothballed as a Result of Negative Marketing ROI
- Sleep Aid Drug Print Ad Triptych
- Consumer Reports Rip Rozerem Ad -- A New One!
- Lunesta's Ad Spending Spree and Other DTC Oddities
- DTC Critters to Strike - Cite New Media Residuals as Issue
- Another Award for Rozerem! This one...not so good.
- Cramer-Krasselt Sucks
- Rozerem's Cheapskate Sweepstakes Violates Children's Online Privacy Protection Act
- Takeda Plots New Rozerem Campaign?
- What do Abe Lincoln, a beaver, and a bong have in common?
- Rozerem DTC Ads: New Paradigm or Paradox?
- Rozerem Ad Spending Exceeds Sales!
- What is a Marketer's Goal: Legacy or Sales Today!?
- Takeda - Fire These Guys!
- Call for a Rozerem Prescription Boycott!
- Back to School for Takeda, Rozerem, and Abe Lincoln!
- Pharma Marketing Sitcoms as Brand Extensions
- PhRMA Responds to My Rozerem Ad "Concern"
- Rozerem DTC Emperor (Still) Has No Clothes
- Tilting Again at the PhRMA Windmill
- Takeda: It Isn't a Reminder Ad --- Wha!!!
- Rozerem Reverts to Reminder TV Ads
- Lincoln Shot Dead! Beaver Sought for Questioning
- DTC in the New Era
- What Was Blogworthy in 2006? A Review
- Revamping the Lunesta Ad Campaign
- Am I Dreaming, or Is This a Rozerem Ad?
- Influencing the Dialogue: Marketers Suck at It!
- What a Difference a Day Makes!
- Lunesta, Google, and "bAdWords"
- Rozerem Sleeper Cell at Pri-Med Conference
- AmbienCR and Lunesta Duke It Out on Web
- Rozerem Ads Innovatively Ineffectual
- Interpretation of Ads: Hokey vs. Horny
- Snark Meter
- Imprecise DTC Benefit Messages
- Odds & Ends & Interpretations
- PhRMA's OOA Issues First Report
- (¼±»ý´Ô) Á¤Ç°100%!! ºÒ [Spam DTC Ad]
- Pharma eMarketing in a Slump
- Rozerem Beaver Buzz
- Confusing Creativity with Mission
- Lunesta, a Sleeping Dog
- DTC Menagerie & Bad Buzz
- Rozerem Ads Dis Lincoln, Show Beaver
- More Reminder Ad Sightings
- Wake Up PhRMA! or Tilting at Windmills
- Lunesta: Golden or Bitter Pill?
- Sepracor Sneaks In Lunesta Reminder Ad
- FDA, Coupons, and Sleep Aid DTC Ads
- Insomnia - the Next DTC Frontier
- Pharma Marketing Newspeak
|
Special Supplement
Direct-to-Consumer Advertising
Volume Two: DTC in the New Era
DTC advertising is set for major changes in light of public criticism, but also in reaction to the changing reality of the marketplace where there is less need for a one size fits all solution. DTC must evolve and marketers must pay more attention to measuring and improving its effectiveness. Otherwise, billions of dollars will continue to be wasted. This volume is devoted to DTC best practices with a focus on techniques for improving DTC efficacy and return on investment, which is generally considered to be declining.
TABLE OF CONTENTS
Order both Volume One and Volume Two and SAVE! (Click Here)
Order and pay for this Special Supplement (DTC Vol 2) now using your credit card...
ONLY $29.95
Download PDF file immediately after paying:
If you wish to be pay by check or credit card off-line, please use:
Printable Order Form
Special Supplement
Direct-to-Consumer Advertising
Volume One
The collection of articles and commentary in this first Pharma Marketing News Special Supplement chronicles the emerging issues of direct-to-consumer (DTC) advertising and presents pro and con opinions from experts on how DTC needs to adapt in the post-Vioxx marketing era. Topics include: DTC Pros and Cons, Straight-Talking DTC, Communicating Risk, Biotech DTC, Print DTC, and more.
TABLE OF CONTENTS
Order both Volume One and Volume Two and SAVE! (Click Here)
Order and pay for this Special Supplement (DTC Vol 1) now using your credit card...
ONLY $29.95
Download PDF file immediately after paying:
If you wish to be pay by check or credit card off-line, please use:
Printable Order Form
|
|